Zobrazeno 1 - 10
of 45
pro vyhledávání: '"L P, Colly"'
Publikováno v:
European Journal of Haematology. 41:489-495
Increased dosages of cytosine arabinoside (Ara-C) have been shown to be active in remission induction and consolidation treatment of patients with primary refractory acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin's lymphoma (lyNHL).
Publikováno v:
European Journal of Haematology. 40:198-204
50 patients (aged 18-58 years) with acute myelogenous leukaemia after a preleukaemic phase (n = 14), acute myelogenous leukaemia that previously failed to respond to conventional chemotherapy (n = 9) or relapsed disease (n = 27) were given remission
Publikováno v:
Scandinavian Journal of Haematology. 36:7-16
SUMMARY Fifty two patients (aged 15–57 years) with primarily failed and relapsed acute myelogenous (AML) or lymphoblastic leukemia (ALL) and with high-grade non-Hodgkin's lymphoma (NHL) have been treated with intermediate dose cytosine arabinoside.
Autor:
M. E. Cromheecke, K. C. J. Keyzers, Barbara A. Hutten, Marcel Levi, H. R. Büller, Raymond H. Mak, Maria Prins, L. P. Colly, B. J. M. De Mol
Publikováno v:
Lancet, 356(9224), 97-102. Elsevier Limited
Summary Background Vitamin K antagonist treatment is effective for prevention and treatment of thromboembolic events but frequent laboratory control and dose-adjustment are essential. Small portable devices have enabled patient self-monitoring of ant
Autor:
Frans M. Helmerhorst, Harry R. Büller, L. P. Colly, Kitty W. M. Bloemenkamp, Frits R. Rosendaal, Jan P. Vandenbroucke
Publikováno v:
Archives of internal medicine, 159(1), 65-70. American Medical Association
Background: The magnitude of the relative risk of venous thrombosis caused by low-dose oral contraceptive use is still debated because previous studies might have been affected by diagnostic suspicion and referral bias. Methods: We conducted a case-c
Publikováno v:
Diabetologia. 40:1334-1340
In primary care it is difficult to treat the growing number of non-insulin-dependent diabetic (NIDDM) patients according to (inter)national guidelines. A prospective, controlled cohort study was designed to assess the intermediate term (2 years) effe
Autor:
Pieter H. Reitsma, F. J. M. Van Der Meer, Ernest Briët, S R Poort, P. H. Trienekens, Ted Koster, L. P. Colly, Jan P. Vandenbroucke, Frits R. Rosendaal
Publikováno v:
Blood. 85:2756-2761
A deficiency of protein C (PC), antithrombin, or protein S is strongly associated with deep-vein thrombosis in selected patients and their families. However, the strength of the association with venous thrombosis in the general population is unknown.
Autor:
D. J. Richel, L. P. Colly, P. M. ter Riet, M. G. D. Kester, R. Willemze, M. W. Arentsen-Honders
Publikováno v:
Annals of Hematology. 65:26-32
In this study the hypothesis that inhibition of the de novo pathway results in stimulation of salvage pathway activity was tested. The key enzyme in the balance between these two pathways is ribonucleotide reductase (RR), which can be inhibited by hy
Autor:
Jeffrey S. Ginsberg, H. Heijboer, A. W. A. Lensing, H. R. Büller, J Wouter ten Cate, L. P. Colly
Publikováno v:
Thrombosis and Haemostasis. 67:510-513
SummaryWe studied the usefulness of the determination of plasma D-dimer levels (using an ELISA) in combination with non-invasive testing with impedance plethysmography (IPG) or real-time ultrasonography (US) for the diagnosis of deep-vein thrombosis
Publikováno v:
British Journal of Cancer
In the present study we demonstrate that Aza-dC in combination with Amsacrine has major antileukaemic properties in patients who have not already received extensive Ara-C therapy. Eight out of 11 patients in their first relapse of acute leukaemia ach